Ira Spector - Y Combinator Founder of SFA Therapeutics
Home›Founders›Ira Spector
Ira Spector, Founder of SFA Therapeutics

Founder at SFA Therapeutics

Dr. Spector is the co-founder of SFA, a microbiome-derived pharmaceutical company focused on new advancements in the treatment inflammatory diseases. An experienced drug developer with over 30 years of experience, he helped develop 34 drugs and 12 medical devices, including Enbrel, Effexor, Protonix, Prevenar, Ozurdex, Botox for Overactive Bladder, Chronic Migraine and Cerebral Palsy. He holds BS degrees in Physics and EE from Washington University, an MBA from Drexel, and a PhD from Rutgers.

Previously at

ICON plc
ICON plc
Allergan Pharmaceutical
Allergan Pharmaceutical
Allergan
Allergan
Wyeth/Pfizer
Wyeth/Pfizer
Pfizer
Pfizer
PA Consulting Group
PA Consulting Group
Mars Electronics, Inc.
Mars Electronics, Inc.
Mars Electronics
Mars Electronics
Air Products & Chemicals, Inc.
Air Products & Chemicals, Inc.
Air Products and Chemicals
Air Products and Chemicals
Alumnus of
University of Medicine & Dentistry of NJ (UMDNJ, now Rutgers University)
University of Medicine & Dentistry of NJ (UMDNJ, now Rutgers University)
Drexel University
Drexel University
Washington University, St. Louis
Washington University, St. Louis